PMLiVE4d
EC approves Celltrion’s RoActemra biosimilar Avtozma for inflammatory diseases
Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...
The Pharma Letter6d
Celltrion wins EC approval for Avtozma, a biosimilar to RoActemra
South Korean firm Celltrion announced that the European Commission (EC) has granted marketing authorization for Avtozma ...
Hosted on MSN6d
EC authorises Celltrion’s Avtozma for multiple indications
Celltrion has secured marketing authorisation from the European Commission (EC) for Avtozma (CT-P47), a biosimilar to Chugai ...